1. Home
  2. SSYS vs PCRX Comparison

SSYS vs PCRX Comparison

Compare SSYS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

HOLD

Current Price

$9.52

Market Cap

784.3M

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.29

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSYS
PCRX
Founded
1989
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
784.3M
1.0B
IPO Year
1994
2011

Fundamental Metrics

Financial Performance
Metric
SSYS
PCRX
Price
$9.52
$26.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$12.75
$32.86
AVG Volume (30 Days)
660.9K
656.9K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$561,461,000.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
$2.76
$9.53
P/E Ratio
N/A
$54.59
Revenue Growth
N/A
3.14
52 Week Low
$8.12
$18.17
52 Week High
$12.88
$27.64

Technical Indicators

Market Signals
Indicator
SSYS
PCRX
Relative Strength Index (RSI) 53.76 71.87
Support Level $8.98 $23.63
Resistance Level $9.22 $26.36
Average True Range (ATR) 0.26 0.92
MACD 0.17 0.24
Stochastic Oscillator 70.23 97.01

Price Performance

Historical Comparison
SSYS
PCRX

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: